410 related articles for article (PubMed ID: 12534330)
1. Management of vasodilatory shock: defining the role of arginine vasopressin.
Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
[TBL] [Abstract][Full Text] [Related]
2. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
[TBL] [Abstract][Full Text] [Related]
4. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
[TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin in advanced vasodilatory shock.
De Backer D; Creteur J; Vincent JL
Circulation; 2003 Nov; 108(19):e142; author reply e142. PubMed ID: 14610005
[No Abstract] [Full Text] [Related]
6. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial.
Torgersen C; Dünser MW; Wenzel V; Jochberger S; Mayr V; Schmittinger CA; Lorenz I; Schmid S; Westphal M; Grander W; Luckner G
Intensive Care Med; 2010 Jan; 36(1):57-65. PubMed ID: 19756505
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
Knotzer H; Poidinger B; Kleinsasser A
Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
[TBL] [Abstract][Full Text] [Related]
8. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
[TBL] [Abstract][Full Text] [Related]
9. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
Agrawal A; Singh VK; Varma A; Sharma R
Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
[TBL] [Abstract][Full Text] [Related]
10. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
Lee CS
Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
[No Abstract] [Full Text] [Related]
11. Arginine vasopressin vs. terlipressin in the treatment of shock states.
Singer M
Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
[TBL] [Abstract][Full Text] [Related]
12. Arginine vasopressin in the treatment of vasodilatory septic shock.
Holmes CL; Walley KR
Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):275-86. PubMed ID: 18683474
[TBL] [Abstract][Full Text] [Related]
13. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
14. Plasma copeptin levels before and during exogenous arginine vasopressin infusion in patients with advanced vasodilatory shock.
Torgersen C; Luckner G; Morgenthaler NG; Jochberger S; Schmittinger CA; Wenzel V; Hasibeder WR; Grander W; Dünser MW
Minerva Anestesiol; 2010 Nov; 76(11):905-12. PubMed ID: 20386508
[TBL] [Abstract][Full Text] [Related]
15. Arginine vasopressin in vasodilatory shock.
Fuchs FD; Filho JW
Circulation; 2003 Nov; 108(19):e141; author reply e141. PubMed ID: 14610004
[No Abstract] [Full Text] [Related]
16. Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.
Lechner E; Hofer A; Mair R; Moosbauer W; Sames-Dolzer E; Tulzer G
Eur J Pediatr; 2007 Dec; 166(12):1221-7. PubMed ID: 17225160
[TBL] [Abstract][Full Text] [Related]
17. Dear vasopressin, where is your place in septic shock?
Duenser MW; Hasibeder WR
Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
[TBL] [Abstract][Full Text] [Related]
18. Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond.
Dünser MW; Westphal M
Curr Opin Anaesthesiol; 2008 Apr; 21(2):122-7. PubMed ID: 18443477
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives.
Krismer AC; Wenzel V; Mayr VD; Voelckel WG; Strohmenger HU; Lurie K; Lindner KH
Curr Opin Crit Care; 2001 Jun; 7(3):157-69. PubMed ID: 11436522
[TBL] [Abstract][Full Text] [Related]
20. The role of vasopressin in the treatment of vasodilation in shock states.
Rozenfeld V; Cheng JW
Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
